Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gefitinib”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00014183
What this trial is testing

ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney Cancer

Who this might be right for
Kidney Cancer
University of Maryland, Baltimore
Not applicableStudy completedNCT00252759
What this trial is testing

Iressa Case Control Study in Japan

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 6,000
Early research (Phase 1)Study completedNCT01570296
What this trial is testing

A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR

Who this might be right for
Non-Small Cell Lung CancerSolid Tumors
National Cancer Centre, Singapore 38
Testing effectiveness (Phase 2)Study completedNCT00298688
What this trial is testing

IRESSA in Relapsed and Refractory Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 56
Large-scale testing (Phase 3)Study completedNCT01024413
What this trial is testing

Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 Mutations

Who this might be right for
Thoracic Neoplasms
Chinese Society of Lung Cancer 256
Testing effectiveness (Phase 2)Ended earlyNCT00237900
What this trial is testing

Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer

Who this might be right for
Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
AstraZeneca 34
Testing effectiveness (Phase 2)Study completedNCT00509002
What this trial is testing

Iressa Study in Patients With Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
M.D. Anderson Cancer Center 37
Testing effectiveness (Phase 2)Looking for participantsNCT07477457
What this trial is testing

Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma

Who this might be right for
OsteosarcomaMetastasis
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00238628
What this trial is testing

A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Stanford University 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT03040973
What this trial is testing

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

Who this might be right for
Advanced Solid Tumors Which Are cMET-dependent
Novartis Pharmaceuticals 29
Post-approval studies (Phase 4)Temporarily pausedNCT01720901
What this trial is testing

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00241475
What this trial is testing

Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy

Who this might be right for
Prostate Cancer
AstraZeneca 30
Testing effectiveness (Phase 2)Ended earlyNCT00198159
What this trial is testing

A Phase II Study of Iressa in Patients With Chemo Refractory Germ Cell Tumors Expressing EGFR

Who this might be right for
Refractory Germ Cell Tumors Expressing EGRF
Indiana University 21
Testing effectiveness (Phase 2)Study completedNCT00052208
What this trial is testing

Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 158
Testing effectiveness (Phase 2)Study completedNCT00126555
What this trial is testing

Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer

Who this might be right for
Recurrent Skin CancerSquamous Cell Carcinoma of the Skin
National Cancer Institute (NCI) 23
Large-scale testing (Phase 3)UnknownNCT02518802
What this trial is testing

Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung Adenocarcinoma

Who this might be right for
Lung Neoplasms
Tang-Du Hospital 220
Testing effectiveness (Phase 2)Study completedNCT00553254
What this trial is testing

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
Pfizer 55
Testing effectiveness (Phase 2)Study completedNCT00049556
What this trial is testing

Gefitinib in Treating Patients With Cervical Cancer

Who this might be right for
Cervical CancerFallopian Tube CancerOvarian Cancer+1 more
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT01085136
What this trial is testing

LUX-Lung 5: Afatinib Plus Weekly Paclitaxel Versus Investigator's Choice of Single Agent Chemotherapy Following Afatinib Monotherapy in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 1,154
Testing effectiveness (Phase 2)UnknownNCT00614809
What this trial is testing

Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastasis
Guangdong Provincial People's Hospital 45
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation